Charite

charite.de

Charite Berlin sees itself as a top-level European location for medical research and patient care. Originally established in 1710 as a quarantine hospital outside the gates of Berlin, the Charité is inseparably linked with innovative scientific, medical and nursing achievements as well as with the names of outstanding physicians, including the pathologist Rudolf Virchow, the surgeon Ferdinand Sauer-Bruch and the founder of modern bacteriology, Robert Koch.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

DIGITAL HEALTHCARE

COMMURE INTRODUCES NEW MODEL TO ACCELERATE TRANSFORMATION IN HEALTHCARE WITH COMMUREOS

Commure | November 14, 2022

news image

To help healthcare organizations hurdle long-standing barriers to meaningful transformation and drive exponential innovation at scale, Commure, Inc. today introduced CommureOS, a revolutionary transformation platform purpose-built for healthcare, at HLTH 2022. CommureOS is designed to give healthcare organizations the power to synthesize and maximize their existing solutions as well as easily build and rapidly deploy intelligent workflows to enhance clinical, operational, and financ...

Read More

GNS HEALTHCARE PRESENTS VERIFIED USE OF AI TO CLASSIFY DRIVERS OF RESPONSE TO IMMUNE CHECKPOINT INHIBITOR (ICI) THERAPY

GNS Healthcare | July 22, 2020

news image

GNS Healthcare (GNS), a leading AI and simulation company, presents results that validate the use of AI to accurately classify tumors based on their immunogenicity and predict response to immune checkpoint inhibitor (ICI) therapy using real-world data. The study showcases the power of causal AI to capture biomarkers and mechanisms, in addition to PD(L)1 and tumor mutation burden (TMB), that are consistent with known immunology. These markers, including CXCL13 upregulation and STK11 mutation, are...

Read More

HEALTH TECHNOLOGY

ALEXANDRA CLYDE APPOINTED TO SEQUANA MEDICAL BOARD OF DIRECTORS

Sequana Medical NV | August 29, 2022

news image

Sequana Medical NV a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer, announces the appointment of Alexandra Clyde as an independent Non-Executive Director of the Company. Ms. Clyde is a highly experienced global business executive with an exceptional understanding and track record of successfully navigating health economics and reimbursement in the medical device industry. The Company also announces that Erik Amble will step down as a memb...

Read More

83% OF MEDICAL IMAGING DEVICES RUN ON UNBACKED OPERATING SYSTEMS

HITInfrastructure | March 13, 2020

news image

1.2 million IoT devices in thousands of physical locations across enterprise IT and healthcare organizations in the US. Researchers found that the over 50 percent jump was due to the Windows 7 operating systems reaching its end of life, leaving hospital organizations vulnerable to attacks that could disrupt care or expose sensitive medical information. High-profile, IoT-focused cyberattacks force industries to recognize and manage the risks associated with deploying IoT devices to protect ...

Read More
news image

DIGITAL HEALTHCARE

COMMURE INTRODUCES NEW MODEL TO ACCELERATE TRANSFORMATION IN HEALTHCARE WITH COMMUREOS

Commure | November 14, 2022

To help healthcare organizations hurdle long-standing barriers to meaningful transformation and drive exponential innovation at scale, Commure, Inc. today introduced CommureOS, a revolutionary transformation platform purpose-built for healthcare, at HLTH 2022. CommureOS is designed to give healthcare organizations the power to synthesize and maximize their existing solutions as well as easily build and rapidly deploy intelligent workflows to enhance clinical, operational, and financ...

Read More
news image

GNS HEALTHCARE PRESENTS VERIFIED USE OF AI TO CLASSIFY DRIVERS OF RESPONSE TO IMMUNE CHECKPOINT INHIBITOR (ICI) THERAPY

GNS Healthcare | July 22, 2020

GNS Healthcare (GNS), a leading AI and simulation company, presents results that validate the use of AI to accurately classify tumors based on their immunogenicity and predict response to immune checkpoint inhibitor (ICI) therapy using real-world data. The study showcases the power of causal AI to capture biomarkers and mechanisms, in addition to PD(L)1 and tumor mutation burden (TMB), that are consistent with known immunology. These markers, including CXCL13 upregulation and STK11 mutation, are...

Read More
news image

HEALTH TECHNOLOGY

ALEXANDRA CLYDE APPOINTED TO SEQUANA MEDICAL BOARD OF DIRECTORS

Sequana Medical NV | August 29, 2022

Sequana Medical NV a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer, announces the appointment of Alexandra Clyde as an independent Non-Executive Director of the Company. Ms. Clyde is a highly experienced global business executive with an exceptional understanding and track record of successfully navigating health economics and reimbursement in the medical device industry. The Company also announces that Erik Amble will step down as a memb...

Read More
news image

83% OF MEDICAL IMAGING DEVICES RUN ON UNBACKED OPERATING SYSTEMS

HITInfrastructure | March 13, 2020

1.2 million IoT devices in thousands of physical locations across enterprise IT and healthcare organizations in the US. Researchers found that the over 50 percent jump was due to the Windows 7 operating systems reaching its end of life, leaving hospital organizations vulnerable to attacks that could disrupt care or expose sensitive medical information. High-profile, IoT-focused cyberattacks force industries to recognize and manage the risks associated with deploying IoT devices to protect ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us